Market Overview:
The global automated DNA and RNA synthesizer market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for nucleic acids from various applications such as medical, laboratory, and biochemistry research institutions. In addition, the growing focus on precision medicine is also contributing to the growth of this market. The global automated DNA and RNA synthesizer market can be segmented on the basis of type into 10-column DNA and RNA synthesizers, 12-column DNA and RNA synthesizers, 96-column DNA and RNA synthesizers.
Product Definition:
An automated DNA and RNA synthesizer is a machine that can chemically create strands of DNA or RNA, sometimes many at a time. Automated DNA and RNA synthesizers are used in research labs to create custom strands of DNA or RNA for experiments, as well as to produce large quantities of specific genetic sequences for further study.
10-Column DNA and RNA Synthesizer:
10-Column DNA and RNA Synthesizer Market Size, Share & Trends Analysis Report By Application (Research, Hospitals), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2020 - 2027 -> The global 10-column DNA and RNA synthesizer market size was valued at USD 8.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2020 to 2027.
12-Column DNA and RNA Synthesizer:
12-column DNA and RNA synthesizer is a machine that can make nucleic acid (DNA or RNA) chains of any length. It has 12 input channels, each with the ability to receive a molecule of deoxynucleotide triphosphate (dNTP), deoxyribonucleotide triphosphate (dRNA), or single-stranded DNA as an input.
Application Insights:
Medical application segment accounted for the largest revenue share in 2017. The medical research sector is anticipated to be the fastest growing segment over the forecast period owing to an increase in demand for advanced therapeutics and rising incidences of genetic disorders.
DNA and RNA synthesizers are widely used across various research institutes, hospitals, diagnostic centers and pharmaceutical companies for numerous applications such as drug discovery & development, clinical diagnostics testing, therapeutic research & development. The increasing usage of automated DNA/RNA synthesizers has enabled researchers to achieve higher accuracy while designing oligonucleotide primers that are used in polymerase chain reaction (PCR). This has led to enhanced efficiency during DNA/RNA synthesis procedures thereby contributing towards growth in revenue generation within this segment.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of pharmaceutical and biotechnology companies, which are engaged in R&D activities for new drug development. Moreover, increasing investments by these companies for automation of various steps involved in drug discovery process is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as rising healthcare expenditure and improving healthcare infrastructure coupled with growing awareness regarding advanced treatment options leading towards better health outcomes. Furthermore, government initiatives encouraging domestic production levels are likely to support regional demand over the next eight years time frame.
The European market also accounted for a significant share due to high research & development (R&D) activities undertaken by major pharmaceutical.
Growth Factors:
- Increasing demand for nucleic acids in research and development activities
- Growing number of biotechnology and pharmaceutical companies
- Rising prevalence of genetic disorders
- Technological advancements in automated DNA and RNA synthesizer market
- Increasing funding for life science research
Scope Of The Report
Report Attributes
Report Details
Report Title
Automated DNA and RNA Synthesizer Market Research Report
By Type
10-Column DNA and RNA Synthesizer, 12-Column DNA and RNA Synthesizer, 96-Column DNA and RNA Synthesizer
By Application
Medical, Laboratory, Biochemistry Research Institution
By Companies
General Electric, Thermo Fisher Scientific, Tekna Plasma Systems, BioAutomation Corporation, Polygen GmbH, GlobalSpec, Biolytic Lab Performance, Beckman Coulter, ACTGene, Precision System Science, CSBio, Genscript Biotech, Protein Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Automated DNA and RNA Synthesizer Market Report Segments:
The global Automated DNA and RNA Synthesizer market is segmented on the basis of:
Types
10-Column DNA and RNA Synthesizer, 12-Column DNA and RNA Synthesizer, 96-Column DNA and RNA Synthesizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Laboratory, Biochemistry Research Institution
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- General Electric
- Thermo Fisher Scientific
- Tekna Plasma Systems
- BioAutomation Corporation
- Polygen GmbH
- GlobalSpec
- Biolytic Lab Performance
- Beckman Coulter
- ACTGene
- Precision System Science
- CSBio
- Genscript Biotech
- Protein Technologies
Highlights of The Automated DNA and RNA Synthesizer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10-Column DNA and RNA Synthesizer
- 12-Column DNA and RNA Synthesizer
- 96-Column DNA and RNA Synthesizer
- By Application:
- Medical
- Laboratory
- Biochemistry Research Institution
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automated DNA and RNA Synthesizer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An automated DNA and RNA synthesizer is a machine that can create large quantities of genetic material, such as DNA or RNA. This material can be used to create new organisms or medicines.
Some of the key players operating in the automated dna and rna synthesizer market are General Electric, Thermo Fisher Scientific, Tekna Plasma Systems, BioAutomation Corporation, Polygen GmbH, GlobalSpec, Biolytic Lab Performance, Beckman Coulter, ACTGene, Precision System Science, CSBio, Genscript Biotech, Protein Technologies.
The automated dna and rna synthesizer market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Automated DNA and RNA Synthesizer Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Automated DNA and RNA Synthesizer Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Automated DNA and RNA Synthesizer Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Automated DNA and RNA Synthesizer Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Automated DNA and RNA Synthesizer Market Size & Forecast, 2020-2028 4.5.1 Automated DNA and RNA Synthesizer Market Size and Y-o-Y Growth 4.5.2 Automated DNA and RNA Synthesizer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10-Column DNA and RNA Synthesizer
5.2.2 12-Column DNA and RNA Synthesizer
5.2.3 96-Column DNA and RNA Synthesizer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Laboratory
6.2.3 Biochemistry Research Institution
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Automated DNA and RNA Synthesizer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Automated DNA and RNA Synthesizer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10-Column DNA and RNA Synthesizer
9.6.2 12-Column DNA and RNA Synthesizer
9.6.3 96-Column DNA and RNA Synthesizer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Laboratory
9.10.3 Biochemistry Research Institution
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10-Column DNA and RNA Synthesizer
10.6.2 12-Column DNA and RNA Synthesizer
10.6.3 96-Column DNA and RNA Synthesizer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Laboratory
10.10.3 Biochemistry Research Institution
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10-Column DNA and RNA Synthesizer
11.6.2 12-Column DNA and RNA Synthesizer
11.6.3 96-Column DNA and RNA Synthesizer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Laboratory
11.10.3 Biochemistry Research Institution
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10-Column DNA and RNA Synthesizer
12.6.2 12-Column DNA and RNA Synthesizer
12.6.3 96-Column DNA and RNA Synthesizer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Laboratory
12.10.3 Biochemistry Research Institution
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10-Column DNA and RNA Synthesizer
13.6.2 12-Column DNA and RNA Synthesizer
13.6.3 96-Column DNA and RNA Synthesizer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Laboratory
13.10.3 Biochemistry Research Institution
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Automated DNA and RNA Synthesizer Market: Competitive Dashboard
14.2 Global Automated DNA and RNA Synthesizer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 General Electric
14.3.2 Thermo Fisher Scientific
14.3.3 Tekna Plasma Systems
14.3.4 BioAutomation Corporation
14.3.5 Polygen GmbH
14.3.6 GlobalSpec
14.3.7 Biolytic Lab Performance
14.3.8 Beckman Coulter
14.3.9 ACTGene
14.3.10 Precision System Science
14.3.11 CSBio
14.3.12 Genscript Biotech
14.3.13 Protein Technologies